Modelling the economic impact of substandard uterotonics on postpartum haemorrhage in Nigeria: safeguarding medicine quality can reduce costs and contribute towards universal health coverage
This study demonstrates that use of quality-assured uterotonics would result in substantial reductions in the economic and health burden of PPH and contribute to decreasing maternal mortality and morbidity. Use of substandard uterotonics leads to increased out-of-pocket expenses and costs to health systems, which should be prevented to promote universal health coverage (UHC). Medicines quality assurance improves health outcomes and results in cost savings for governments to scale their implementation of UHC.
Authors
- Petra Procter
- Chimezie Anyakora (ORCID: https://orcid.org/0000-0002-7872-1380)
- Sachiko Ozawa (ORCID: https://orcid.org/0000-0001-7608-9038)
- A. Metin Gülmezog̈lu (ORCID: https://orcid.org/0000-0003-4674-0998)
- Colleen R. Higgins (ORCID: https://orcid.org/0000-0002-7900-9539)
- Lester Chinery
- Sara Rushwan (ORCID: https://orcid.org/0000-0003-2538-4955)
- Yi-Fang Ashley Lee (ORCID: https://orcid.org/0000-0001-8648-9465)
Institutions
- University of North Carolina at Chapel Hill (US)
- Concept Foundation (CH)
- Pan-Atlantic University (NG)
Publication Details
- Journal
- BMJ Public Health
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/bmjph-2023-000624
- Citations
- 1
- Primary Topic
- Maternal and fetal healthcare
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- Johnson and Johnson Foundation